Box score
Abrexa Pharmaceuticals, Inc.
Reported $23M sold in a new Form D filed April 28, 2025 (San Diego, California).
- Biggest raise
- $23M filed Apr 28, 2025
- League
- Bio & Health Other Health Care
- Based in
- San Diego, California
- Season rank
- #163 of 1,311 in the Bio & Health League; #1035 of 12,397 overall (2025)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-04-28 | New notice | $23M | $23M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1529349.
Similar raises, 2025
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Alessa Therapeutics, Inc. | Bio & Health | $25.4M |
| 2 | Magnus Medical, Inc. | Bio & Health | $23.7M |
| 3 | Tioga Cardiovascular, Inc. | Bio & Health | $22.9M |
| 4 | ClearNote Health, Inc. | Bio & Health | $21.8M |
| 5 | Oncocyte Corp | Bio & Health | $21.7M |
| 6 | VahatiCor, Inc. rookie | Bio & Health | $21.2M |